John H. Sampson, M.D., Ph.D.

Affiliations: 
Surgery, Immunology, Pathology, Radiation Oncology Duke Medical School, Durham, NC, United States 
Area:
translational immunotherapy, EGFR-tyrosine kinase inhibitor ZD1839
Website:
http://neuro.surgery.duke.edu/faculty/details/0108354
Google:
"John Sampson"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, et al. (2021) Targeting Immunometabolism in Glioblastoma. Frontiers in Oncology. 11: 696402
Ellingson BM, Sampson JH, Achrol AS, et al. (2021) Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Swartz AM, Congdon KL, Nair SK, et al. (2021) A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope. Npj Vaccines. 6: 12
Gromeier M, Brown MC, Zhang G, et al. (2021) Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy. Nature Communications. 12: 352
Brady M, Raghavan R, Sampson J. (2020) Determinants of Intraparenchymal Infusion Distributions: Modeling and Analyses of Human Glioblastoma Trials. Pharmaceutics. 12
Gedeon PC, Champion CD, Rhodin KE, et al. (2020) Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook. Expert Review of Clinical Pharmacology
Hotchkiss KM, Sampson JH. (2020) Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. Journal of Neuro-Oncology
Gedeon PC, Streicker MA, Schaller TH, et al. (2020) GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody. Plos One. 15: e0236374
Batich KA, Mitchell DA, Healy P, et al. (2020) Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Khasraw M, Reardon DA, Weller M, et al. (2020) PD-1 inhibitors: Do they have a future in the treatment of glioblastoma? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...